317 related articles for article (PubMed ID: 25032197)
1. Infectious burden and atherosclerosis: A clinical issue.
Sessa R; Pietro MD; Filardo S; Turriziani O
World J Clin Cases; 2014 Jul; 2(7):240-9. PubMed ID: 25032197
[TBL] [Abstract][Full Text] [Related]
2. Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Ioannidis A; Boufidou F; Moutafis S; Nicolaou C
Nephrology (Carlton); 2005 Jun; 10(3):256-63. PubMed ID: 15958038
[TBL] [Abstract][Full Text] [Related]
3. The infectious burden in atherothrombosis.
Tufano A; Di Capua M; Coppola A; Conca P; Cimino E; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2012 Jul; 38(5):515-23. PubMed ID: 22660918
[TBL] [Abstract][Full Text] [Related]
4. Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Kopp H; Rippin G; Victor A; Hafner G; Schlumberger W; Meyer J;
Circulation; 2002 Jan; 105(1):15-21. PubMed ID: 11772870
[TBL] [Abstract][Full Text] [Related]
5. High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker.
Jha HC; Prasad J; Mittal A
Heart Vessels; 2008 Nov; 23(6):390-6. PubMed ID: 19037586
[TBL] [Abstract][Full Text] [Related]
6. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis.
Rosenfeld ME; Campbell LA
Thromb Haemost; 2011 Nov; 106(5):858-67. PubMed ID: 22012133
[TBL] [Abstract][Full Text] [Related]
7. Infections and atheromatous plaque: current therapeutic implications.
Charakida M; Tousoulis D
Curr Pharm Des; 2013; 19(9):1638-50. PubMed ID: 23016720
[TBL] [Abstract][Full Text] [Related]
8. [Implication and mode of action of infectious agents in the formation of atheromatous plaques. Infection and atherosclerosis].
Lizard G; Gambert P
Pathol Biol (Paris); 2001 Dec; 49(10):824-9. PubMed ID: 11776694
[TBL] [Abstract][Full Text] [Related]
9. Infectious agents and atherosclerosis: current perspectives and unsolved issues.
Kol A; Santini M
Ital Heart J; 2004 May; 5(5):350-7. PubMed ID: 15185898
[TBL] [Abstract][Full Text] [Related]
10. Association between Bacterial Infection and Peripheral Vascular Disease: A Review.
Budzyński J; Wiśniewska J; Ciecierski M; Kędzia A
Int J Angiol; 2016 Mar; 25(1):3-13. PubMed ID: 26900306
[TBL] [Abstract][Full Text] [Related]
11. Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.
Szklo M; Ding J; Tsai MY; Cushman M; Polak JF; Lima J; Barr RG; Sharrett AR
J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):747-51. PubMed ID: 19444130
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
Ngeh J; Anand V; Gupta S
Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
[TBL] [Abstract][Full Text] [Related]
13. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate.
Neureiter D; Heuschmann P; Stintzing S; Kolominsky-Rabas P; Barbera L; Jung A; Ocker M; Maass M; Faller G; Kirchner T
Atherosclerosis; 2003 May; 168(1):153-62. PubMed ID: 12732399
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients.
Hagiwara N; Toyoda K; Inoue T; Shimada H; Ibayashi S; Iida M; Okada Y
J Stroke Cerebrovasc Dis; 2007; 16(4):145-52. PubMed ID: 17689410
[TBL] [Abstract][Full Text] [Related]
15. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis.
Mayr M; Kiechl S; Willeit J; Wick G; Xu Q
Circulation; 2000 Aug; 102(8):833-9. PubMed ID: 10952949
[TBL] [Abstract][Full Text] [Related]
16. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
Ismail A; Khosravi H; Olson H
Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
[TBL] [Abstract][Full Text] [Related]
17. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis.
Slocum C; Kramer C; Genco CA
J Intern Med; 2016 Jul; 280(1):114-28. PubMed ID: 26791914
[TBL] [Abstract][Full Text] [Related]
18. Link between intracellular pathogens and cardiovascular diseases.
Gurfinkel E
Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S33-S36. PubMed ID: 11869268
[TBL] [Abstract][Full Text] [Related]
19. Detection of infectious agents by polymerase chain reaction in human aortic wall.
Reszka E; Jegier B; Wasowicz W; Lelonek M; Banach M; Jaszewski R
Cardiovasc Pathol; 2008; 17(5):297-302. PubMed ID: 18402822
[TBL] [Abstract][Full Text] [Related]
20. No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis.
Weiss TW; Kvakan H; Kaun C; Prager M; Speidl WS; Zorn G; Pfaffenberger S; Huk I; Maurer G; Huber K; Wojta J
J Clin Pathol; 2006 Nov; 59(11):1186-90. PubMed ID: 16644879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
